We are live on ! Find out more
GCP

GSA Capital Partners Portfolio holdings

AUM $1.59B
1-Year Est. Return 39.81%
This Fund
S&P 500
This Quarter Est. Return
+13.93%
1 Year Est. Return
+39.81%
3 Year Est. Return
+94.75%
5 Year Est. Return
+73.44%
10 Year Est. Return
+404.29%
AUM
$1.19B
AUM Growth
+$22.1M
Cap. Flow
-$83.9M
Cap. Flow %
-7.06%
Top 10 Hldgs %
3.97%
Holding
2,047
New
610
Increased
399
Reduced
421
Closed
613

Sector Composition

Rank Sector Weight
1 Healthcare 14.56%
2 Technology 13.55%
3 Consumer Discretionary 13.11%
4 Financials 12.97%
5 Industrials 10.64%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
UTHR icon
926
United Therapeutics
UTHR
$23.1B
$410K 0.03%
1,864
+646
+53% +$149K
XNTK icon
927
State Street SPDR NYSE Technology ETF
XNTK
$2.23B
$410K 0.03%
2,499
-434
-15% -$64.1K
DFIN icon
928
Donnelley Financial Solutions
DFIN
$1.16B
$409K 0.03%
+6,562
New +$374K
FIVE icon
929
Five Below
FIVE
$13.5B
$409K 0.03%
+1,920
New +$352K
CRCT icon
930
Cricut
CRCT
$1.22B
$408K 0.03%
+61,945
New +$476K
CMLS
931
DELISTED
Cumulus Media Inc. Class A Common Stock
CMLS
$408K 0.03%
76,668
+51,081
+200% +$258K
IRDM icon
932
Iridium Communications
IRDM
$5.29B
$407K 0.03%
9,899
-41,411
-81% -$1.64M
DXPE icon
933
DXP Enterprises
DXPE
$2.98B
$405K 0.03%
12,011
-1,070
-8% -$34.9K
VZ icon
934
Verizon
VZ
$196B
$405K 0.03%
+10,742
New +$380K
CVRX icon
935
CVRx
CVRX
$63.4M
$404K 0.03%
+12,856
New +$241K
ADAP
936
DELISTED
Adaptimmune Therapeutics
ADAP
$403K 0.03%
+508,808
New +$287K
GPOR icon
937
Gulfport Energy Corp
GPOR
$2.88B
$403K 0.03%
3,029
-5,027
-62% -$647K
REGN icon
938
Regeneron Pharmaceuticals
REGN
$80.8B
$403K 0.03%
+459
New +$378K
ATRA icon
939
Atara Biotherapeutics
ATRA
$76.1M
$402K 0.03%
+31,375
New +$732K
OIH icon
940
VanEck Oil Services ETF
OIH
$1.84B
$402K 0.03%
+1,300
New +$417K
NCLH icon
941
Norwegian Cruise Line
NCLH
$8.84B
$401K 0.03%
20,033
-67,232
-77% -$1.08M
OGE icon
942
OGE Energy
OGE
$9.71B
$401K 0.03%
11,479
-1,962
-15% -$67.7K
BILL icon
943
BILL Holdings
BILL
$4.78B
$400K 0.03%
+4,902
New +$402K
RPRX icon
944
Royalty Pharma
RPRX
$25.3B
$400K 0.03%
14,237
-56,554
-80% -$1.55M
SSTK icon
945
Shutterstock
SSTK
$219M
$400K 0.03%
+8,286
New +$350K
ATEN icon
946
A10 Networks
ATEN
$1.95B
$399K 0.03%
30,330
+665
+2% +$8.06K
AXS icon
947
AXIS Capital
AXS
$7.55B
$399K 0.03%
7,198
+2,263
+46% +$126K
VIP
948
Vulcan Infrastructure and Power Inc. Class A Common Stock
VIP
$37.2M
$398K 0.03%
+59,386
New +$301K
COHU icon
949
Cohu
COHU
$2.5B
$397K 0.03%
+11,217
New +$373K
GTN icon
950
Gray Television
GTN
$552M
$397K 0.03%
44,310
+22,994
+108% +$171K

Similar funds

GSA Capital Partners's Q4 2023 Portfolio in Review

As of Q4 2023, GSA Capital Partners held 2,047 positions worth $1.19B, up 1.9% from $1.17B the previous quarter. Its ten largest holdings account for 4% of the portfolio.

GSA Capital Partners withdrew a net $83.9M in Q4 2023, closing 613 positions and reducing 421 holdings. Its most notable exit was Teck Resources, an estimated $5.81M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 15% of assets, up from 14% a quarter earlier, followed by Technology and Consumer Discretionary.

Against the trend, GSA Capital Partners opened a new position in Aon worth $4.58M.

  • GSA Capital Partners's largest Q4 2023 buy was Aon: 15,721 shares worth $4.58M.
  • GSA Capital Partners added most to Aclaris Therapeutics in Q4 2023, an estimated $4.73M increase.
  • GSA Capital Partners's biggest Q4 2023 reduction was NVIDIA, cutting an estimated $3.48M.
  • GSA Capital Partners fully exited Teck Resources in Q4 2023, selling an estimated $5.81M.
  • GSA Capital Partners's ten largest holdings make up 4% of its $1.19B portfolio in Q4 2023.
  • GSA Capital Partners opened 610 new positions and closed 613 in Q4 2023.
  • GSA Capital Partners's portfolio value rose 1.9% quarter-over-quarter to $1.19B.

Based on GSA Capital Partners's 13F filing for Q4 2023, filed 16 Feb 2024.